Loading…
CervoMed Inc. is projected to decline to $2.18 by 2027, a -16% move from its current price of $2.60. CRVO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.46 | $2.60 | $2.74 | -0.01% |
| Aug 6 | $2.41 | $2.60 | $2.81 | -0.02% |
| Aug 7 | $2.37 | $2.60 | $2.85 | -0.02% |
| Aug 8 | $2.33 | $2.60 | $2.89 | -0.03% |
| Aug 9 | $2.30 | $2.60 | $2.93 | -0.04% |
| Aug 10 | $2.28 | $2.60 | $2.97 | -0.05% |
| Aug 11 | $2.25 | $2.60 | $3.00 | -0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.25 | $2.60 | $3.00 | -0.05% |
| Week 2 | $2.12 | $2.60 | $3.18 | -0.11% |
| Week 3 | $2.03 | $2.60 | $3.32 | -0.16% |
| Week 4 | $1.95 | $2.59 | $3.45 | -0.21% |
| Week 5 | $1.89 | $2.59 | $3.57 | -0.27% |
| Week 6 | $1.83 | $2.59 | $3.67 | -0.32% |
| Week 7 | $1.78 | $2.59 | $3.78 | -0.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CervoMed Inc. is a clinical-stage biotechnology company that engages in the development and commercialization of treatments for age-related neurologic disorders.
The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood-brain barrier and inhibits the enzyme p38a, with the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression.
CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
CRVO is the ticker for CervoMed Inc. The current price is $2.56.
The company has a market capitalization of $23.7M and is ranked 4600.
The price forecast path is mixed over the coming years, with near-term neutral to bearish signals and longer-term bullish trends. In 2026 the avg is $2.56; in 2027 the avg is $2.14 (bearish); by 2031 the avg rises to $3.14 (bullish), and by 2040 the avg is $3.92 (bullish) with a 2050 avg of $5.67 (bullish).
A major floor 48.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.6% below — buyers have tended to step in here.
The nearest ceiling, 63.1% above — a clean break opens room to run.
A major ceiling 86.9% above — clearing it would confirm fresh momentum.
Key CRVO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRVO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.56 | Buy | $2.58 | Buy |
| MA 10 | $2.66 | Sell | $2.69 | Sell |
| MA 20 | $3.00 | Sell | $2.88 | Sell |
| MA 50 | $3.12 | Sell | $3.18 | Sell |
| MA 100 | $3.52 | Sell | $3.73 | Sell |
| MA 200 | $5.21 | Sell | $4.84 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.16 | Neutral |
| Stoch RSI (14) | 31.66 | Neutral |
| CCI (20) | -82.16 | Neutral |
| Williams %R (14) | -84.85 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -15.96 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 15.15 | Buy |
| TRIX (15) | -0.72 | Sell |
| Awesome (5,34) | -0.64 | Sell |
| Ultimate (7,14,28) | 25.00 | Buy |
| Momentum (10) | -0.50 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 2.47 | Buy |
| ADX (14) | 17.52 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is bearish with RSI14 at 40. The 50-day simple moving average sits at $3.18 and the 200-day simple moving average sits at $5.33, indicating downward pressure relative to longer-term trends.
Support is at $2.45 and resistance is at $4.52, framing a near-term range with a 30-day window between $1.73 and $3.79.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.25 | $2.60 | $3.18 | 0% | Neutral | |
| $1.59 | $2.18 | $3.23 | -16% | Bearish | |
| $1.64 | $2.39 | $3.78 | -8% | Neutral | |
| $1.30 | $2.00 | $3.33 | -23% | Bearish | |
| $1.56 | $2.51 | $4.35 | -3% | Neutral | |
| $1.95 | $3.29 | $5.91 | +27% | Bullish | |
| $1.75 | $3.08 | $5.69 | +18% | Neutral | |
| $1.78 | $3.27 | $6.21 | +26% | Bullish | |
| $1.53 | $2.92 | $5.69 | +12% | Neutral | |
| $1.22 | $2.41 | $4.81 | -7% | Neutral | |
| $1.89 | $4.19 | $9.19 | +61% | Bullish | |
| $2.80 | $6.21 | $14.29 | +139% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.25 | $2.60 | $3.09 | +0.00% |
| September 2026 | $2.03 | $2.47 | $3.13 | -5.06% |
| October 2026 | $2.09 | $2.58 | $3.34 | +4.60% |
| November 2026 | $2.03 | $2.53 | $3.33 | -1.84% |
| December 2026 | $1.89 | $2.39 | $3.18 | -5.87% |
Click any year to see its month-by-month CRVO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CRVO to range from $2.25 to $3.18 through 2026. The $2.60 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CRVO price prediction for 2027 points to an average of $2.18 (low $1.59, high $3.23) — a potential decline of -16% on today's $2.60. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2028, CRVO is projected to trade between $1.64 and $3.78, averaging $2.39 — a potential decline of -8% from today's $2.60. That is up +10% on the projected 2027 average. A consolidation phase looks the most probable path here.
CervoMed Inc.'s 2029 outlook centres on $2.00, within a $1.30 to $3.33 range. That is -16% versus the projected 2028 average. That marks a -23% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2030, CRVO could reach as high as $4.35, with a base case around $2.51 and support toward $1.56 — roughly -3% from $2.60. A consolidation phase looks the most probable path here.
Expect CRVO to range from $1.95 to $5.91 through 2031. The $3.29 average target implies a +27% move from current prices. That is up +31% on the projected 2030 average. Momentum favours further upside here.
The CRVO price prediction for 2032 points to an average of $3.08 (low $1.75, high $5.69) — a potential gain of +18% on today's $2.60. A consolidation phase looks the most probable path here.
In 2033, CRVO is projected to trade between $1.78 and $6.21, averaging $3.27 — a potential gain of +26% from today's $2.60. That is up +6% on the projected 2032 average. Momentum favours further upside here.
CervoMed Inc.'s 2034 outlook centres on $2.92, within a $1.53 to $5.69 range. That is -11% versus the projected 2033 average. That marks a +12% change versus current levels. A consolidation phase looks the most probable path here.
By 2035, CRVO could reach as high as $4.81, with a base case around $2.41 and support toward $1.22 — roughly -7% from $2.60. Price action looks broadly range-bound.
Expect CRVO to range from $1.89 to $9.19 through 2040. The $4.19 average target implies a +61% move from current prices. That is up +74% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The CRVO price prediction for 2050 points to an average of $6.21 (low $2.80, high $14.29) — a potential gain of +139% on today's $2.60. Momentum favours further upside here.
Investing $1,000 in CRVO today (≈ 384.615385 CRVO) could be worth
$2,389.45
+$1,389.45 (+139%) by 2050 · US Dollar
Based on the average projected CRVO price of $6.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRVOwould be worth at today's price.
$1,000 invested in CRVO on Jul 31, 2025 (≈ 121.212121 CRVO) would be worth
$315.15
-$684.85 (-68.5%) today · 0.32× · US Dollar
Based on a CRVO entry price of $8.25 vs. today's $2.6.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.66 | $977.44 | -2.3% |
| 1 month ago | $3.69 | $704.61 | -29.5% |
| 3 months ago | $3.71 | $700.81 | -29.9% |
| 6 months ago | $4.87 | $533.88 | -46.6% |
| 1 year ago | $8.25 | $315.15 | -68.5% |
| All time (5.0y) ago | $41.25 | $63.03 | -93.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRVO forecast.
Our base-case forecast reaches $5.20 around 2050.
Implied market cap at $5.20: $48.15M
Longer-term forecasts show a path toward higher averages later in the horizon. The 2030 avg is $2.37 with a -7.4% ROI and neutral sentiment, illustrating modest upside potential amid near-term softness.
Bullish momentum appears in 2031 (avg $3.14, ROI 22.5, sentiment BULLISH) and again in 2033 (avg $3.14, ROI 22.7, sentiment BULLISH), with continued strength into 2040 (avg $3.92, ROI 53, sentiment BULLISH) and 2050 (avg $5.67, ROI 121.5, sentiment BULLISH).
The forecast also shows downside risk in some mid-cycle years, such as 2027 (avg $2.14, ROI -16.4, BEARISH) and 2029 (avg $1.88, ROI -26.5, BEARISH). Max price projections reach $8.59 in 2040 and $13.04 in 2050, underscoring substantial upside potential alongside variability and uncertainty.
Tap a question to reveal the answer.
2030 avg $2.37; min $1.47; max $4.11; ROI -7.4%; sentiment NEUTRAL.
Forecasts show a mixed near-term path with bearish years in 2027 and 2029 and neutral years in 2026, 2028, and 2030, followed by bullish years in 2031, 2033, 2040, and 2050. The 2050 max is $13.04 with ROI 121.5%.
Yes. The 2040 max is $8.59 and the 2050 max is $13.04, indicating higher-price scenarios in the long term.
Current price is $2.56 and market cap is $23.7M.
Bearish sentiment with RSI 40. The SMA50 is $3.18 and the SMA200 is $5.33. Support is at $2.45 and resistance at $4.52, with a 30-day range of $1.73 to $3.79.
CervoMed Inc. Community Discussion
0Share your CervoMed Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.